Freshly isolated, human peripheral blood T 
tions, can be readily induced to undergo apoptosis when cocultured with either autologous or allogeneic monocytes (Mo) in PMA-containing medium. Incubation of PBT cells with Mo at a ratio of 1:1 for 18 hr resulted in maximal levels (80%o) of apoptotic cell death. The mechanism whereby Mo enable PBT cells to undergo apoptosis in PMA-containing medium appeared to depend on cell-cell contact or close proximity between Mo and PBT cells rather than solely via soluble mediators. It was demonstrated that Mo acquire the ability to prime PBT cells for apoptosis after treatment with PMA and that treated Mo maintain this ability even after fixation with formaldehyde. It was also found that once PBT cells became primed for apoptosis by incubation with PMApretreated Mo, the primed PBT cells were susceptible to apoptosis triggered not only by PMA but also by either ionomycin or by monoclonal antibody crosslinking of T-cell surface molecules such as CD4 and CD3. Interestingly, the degree of apoptosis of CD4+ T cells by crosslinking of CD4 molecules via a combination of gpl20, anti-gpl2O, and goat anti-mouse IgG was significantly greater for T cells primed with PMAtreated Mo than for unprimed T cells. Together, these findings reveal an important role for accessory cells in priming resting PBT cells for apoptosis and suggest a possible Mo-dependent mechanism by which T cells may become primed for apoptosis in human immunodeficiency virus-infected asymptomatic individuals.
Treatment with anti-CD3 antibody, ionomycin, and/or phorbol ester can induce apoptosis in both human and mouse immature thymocytes (1, 2). However, truly resting mature T cells are resistant to the induction of apoptosis (3, 4) , and it is believed that this resistance to apoptosis may be correlated with T-cell maturity. Bcl-2, a known protooncogene that can block apoptosis, is present at much higher levels in mature, peripheral T cells than in immature thymocytes (5) , and, within the mouse thymus, mature CD3bnght thymocytes are largely resistant to apoptosis induced by glucocorticoid treatment compared with immature CD3-/dim thymocytes (6) . Such findings have suggested that upregulation of CD3 expression in thymocytes correlates with cell survival and selection for export into the periphery.
Peripheral blood T (PBT) cells can gradually acquire susceptibility to apoptosis induced by anti-CD3 monoclonal antibody (mAb), antigen, and mitogenic activation, or by cytokine-induced cycling after extended culture in vitro (4) . Apoptosis can be induced as well in T lymphoblasts, transformed T cells, and T-cell hybridomas by treatment with anti-CD3
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antibody, and susceptibility to apoptosis has also been demonstrated with some long-lived T-cell clones (7) . In these cases, it is thought that this acquired susceptibility to apoptosis by mature T cells may be linked to the Fas (CD95)-dependent death pathway (8) . These findings suggest that the programmed cell death (PCD) pathway may be absent or inactivated during differentiation of T lymphocytes but may reappear after prolonged stimulation.
In contrast to PBT cells isolated from healthy individuals, a significant number of PBT cells isolated from human immunodeficiency virus (HIV)-infected individuals die through apoptosis upon overnight culture in vitro (9) . This apoptosis of T cells occurs in both CD4+ and CD8+ cell populations and is enhanced by activation in vitro with anti-CD3 antibody, ionomycin, pokeweed mitogen, or staphylococcal enterotoxin B-i.e., with reagents that stimulate normal PBT cells to proliferate (10, 11) . PBT cells from HIV-infected individuals do express low levels of both activation (12) and CD95 (Fas/ Apo-1) antigens (13) , and they are apparently nondividing cells. Nevertheless, it is still not clear why PBT cells in HIVinfected individuals are so susceptible to apoptosis triggered by T-cell stimulation. An understanding of such a question may be crucial toward understanding the mechanisms underlying the decline in the number of CD4+ lymphocytes that occurs with disease progression in AIDS patients.
To ascertain whether a PCD pathway, similar in nature to that which exists in immature thymocytes, might exist in resting, mature PBT cells, a number of in vitro culture systems were tested and we found that coculturing T purified mAbs specific for CD3 (T3; IgG2) and CD14 (MY4). mAbs against CD4 (19thy5D7), CD20 (Bi), CD8 (21thy2D3), CD56 (N901), and CD6 (6D3) (14, 15) were developed in this laboratory. mAbs against CD16 (3G8) and CD95 (Fas/Apo-1, 7C11) were generous gifts of P. Anderson and M. J. Robertson (Dana-Farber Cancer Institute), respectively. Mouse antigpl20 (HIV-1) mAb was purchased from Intracell (Cambridge, MA).
Purification of PBT Cells and Mo. Human peripheral blood mononuclear cells were isolated by Ficoll/Hypaque (Pharmacia) gradient centrifugation from buffy coats of healthy blood donors; resuspended in culture medium consisting of RPMI 1640 medium, 10% human AB serum, 2 mM L-glutamine, 25 mM Hepes buffer (Sigma), 100 units of penicillin per ml, and 100 jig of streptomycin per ml (GIBCO); and cultured at 37°C in tissue culture flasks. After 1 hr of incubation, nonadherent cells were collected, washed with antibody reaction buffer [2% human AB serum (BioWhittaker) in RPMI 1640 medium] and then treated with a mixture of mAbs specific for CD56 (1:250 diluted ascites), CD20 (1:100 diluted ascites), and CD14 (5 ,ug/ml), which recognize natural killer cells, B cells, and Mo, respectively. For CD4+ cell purification, a mAb specific for CD8 (1:200 ascites) was also included in the mAb solution. Cells were then purified by negative depletion as described (15) and resuspended in culture medium at 106 cells per ml.
Purified PBT cells and CD4+ cells were used in all experiments unless otherwise indicated.
For purification of Mo, E rosette-negative (E-) cells at 2 x 106 cells per ml in culture medium were prepared as described (15) and plated at 5 ml per 25-cm2 flask or 0.5 ml to each well of a 24-well plate (Costar). After 1 hr of incubation at 37°C in 5% C02/95% air, nonadherent cells were removed by washing flasks or plates a total of three times with washing buffer (5% newborn calf serum in RPMI 1640 medium). Remaining adherent cells, consisting of a population of -90% Mo, as determined by flow cytometry with FITC-anti-CD14 antibody, were used directly as Mo in apoptosis induction assays.
Flow Cytometric Analysis ofApoptosis. Cells to be analyzed were collected, washed once with fluorescence-activated cell sorter medium (2% human AB serum in PBS), and incubated with either FITC-anti-CD2 or FITC-anti-CD3 mAb for 20 min on ice. After a wash, cells were resuspended in Hoechst 33342 vital dye (Ho) solution (1 ,ug/ml in RPMI 1640 medium), incubated for 12 min at 37°C, and then immediately placed on ice. Propidium iodide (PI) was added to each sample to give a final concentration of 1 ,ug/ml (both Ho and PI were purchased from Sigma) before flow cytometric analysis. Quantification of apoptotic cell death in the CD3+ population was performed by flow cytometric analysis using an Epics Elite (Coulter) (6) . Cell debris and clumps were excluded from analysis by using forward and side scatter parameters. All fluorescent signals were recorded on a logarithmic scale and analyzed with Epics Elite software.
Apoptosis Induction. Mo were incubated either in culture medium alone or with PMA in culture medium (10 ng/ml) for 1 hr at 37°C and then washed three times. In some experiments, formaldehyde (0.1-1% in RPMI 1640 medium) was added to fix the cells for 15 min at room temperature before washing. To wells containing either treated or untreated Mo, purified PBT cells were added (0.5 ml at 106 cells per ml) and cocultures were incubated for 16-18 hr at 37°C in the presence or absence of various stimuli as indicated. PBT cells were then analyzed for apoptosis as described for the particular experiment.
In some cases, PBT cell surface antigens were crosslinked using saturating concentrations of specific mAbs plus goat anti-mouse IgG (GAMIgG), where indicated (15) (16) .
Staining of Apoptotic Cells and Fluorescence Microscopy. Cells to be examined microscopically were pelleted in Eppendorf tubes by centrifugation for 10 sec at 13,000 rpm. The cell pellet was resuspended, stained with 10 ,ul of Ho solution containing 1 ,ug of PI per ml, placed on ice, and immediately examined under a Zeiss ICM fluorescence microscope with UV excitation and blue emission. Blue fluorescence was visualized when the sample was warmed up during the time of examination. Photographs were taken with either Kodak Tri-X or TMAX 400 film.
RESULTS
PBT Cells Undergo Apoptosis in the Presence of Both Mo and PMA. To define the conditions whereby resting T cells might be induced to undergo apoptosis, a series of preliminary experiments were performed. Our initial studies supported the notion that PBT cells, isolated from normal individuals, are resistant to apoptosis (3, 4) . It was found, for example, that overnight treatment of purified, freshly isolated PBT with PMA, ionomycin, dexamethasone, and anti-CD95 (Fas/ Apo-1) mAb, or mAb crosslinking of cell surface molecules such as CD4 and/or CD3 failed to induce apoptosis (data not shown). In contrast, a significant degree of apoptosis in the CD3+ population was noted when PBT cells were cultured with autologous, E-cells in the presence of PMA as shown in Fig. 1 (D-F) . The effect of the E-cells appears to be density dependent since at a E-/PBT cell ratio of 1:2 -50% of the T (C and H) ; or equal numbers of nonadherent, E-cells (G).
The final volume of all cultures was 0.5 ml except for F (1.5 ml). cells became apoptotic and this increased to >70% when equal numbers of E-and PBT cells were cultured together. However, no further increase in the percentage of apoptotic T cells was observed when greater numbers of E-cells were included in the cultures and, indeed, when high numbers of E-cells were added, larger volumes of media were required to maintain a consistent cell density, because it was found that, at a high cell density, apoptotic cell death of T cells actually decreased from 70% to 52% due to poor metabolic activity of the cells. Without the addition of E-cells, the percentage of PBT cells undergoing apoptosis in PMA-containing medium (Fig.  1B) was only slightly higher than that of PBT cells cultured in medium alone (Fig. 1A) . No apoptosis over background levels was observed for T cells cultured in the presence of an equal number of E-cells when PMA was replaced with ionomycin, dexamethasone, or anti-CD95 (Fas/Apo-1) antibody, or by mAb crosslinking of CD4 and CD3 molecules (data not shown).
Within the E-population, it was found that cells in the adherent population induced a strong degree of T-cell apoptosis in the presence of PMA (Fig. 1H ), yet no apoptosis above background levels was observed when T cells were cultured with nonadherent E-cells (Fig. 1G) . Furthermore, no induction of T-cell apoptosis by adherent cells occurred if PMA was not included in the culture medium (Fig. 1C) . Consistent with these results, proliferation of PBT in PMAcontaining medium, as measured by thymidine incorporation, was 2-fold greater in the presence of 1/10th the number of Mo as in the presence of an equal number of Mo.
In addition, an identical degree of T-cell apoptosis in PMAcontaining medium was found in the presence of either autologous or allogeneic Mo (data not shown). Moreover, it was demonstrated by using purified T subpopulations that not only CD4+ but also CD8+ T cells undergo apoptosis at a high level (80%) through this Mo-dependent mechanism (data not shown).
To confirm the apoptotic nature of Hobright PBT (Fig. 4, lane 2) . The concentration of formaldehyde (0.1%), the fixed Mo were no longer able to prime PBT cells for PMA-induced apoptosis (lane 3). Together, these results suggest that contact between PBT cells and Mo is required to trigger apoptosis in PMA medium. However, we cannot exclude the possibility that the leakage of soluble ligands into the microenvironment of PBT cells from the PMA-pretreated Mo may contribute to the induction of apoptosis.
PMA-Pretreated Mo Enable PBT to Undergo Apoptosis Triggered by Ionomycin, PMA, or Crosslinking of CD3 or CD4. To investigate whether T cells themselves also need to be stimulated in order to initiate the apoptosis process after priming by PMA-treated Mo, Mo were first treated with PMA for 1 hr, washed extensively, and then fixed in 0.1% formaldehyde. To the fixed, PMA-pretreated Mo, fresh PBT cells, some ofwhich had been surface antigen crosslinked using mAb to CD3, CD4, or CD6 plus GAMIgG, were added and cultured in either culture medium alone or culture medium containing ionomycin or PMA as indicated in 6-fold, respectively. In contrast, when resting PBT cells were cocultured with Mo that were not pretreated with PMA prior to fixation, no significant increase in apoptotic cell death of PBT was observed regardless of the stimuli used (Fig. 5A, Mo) , confirming both that Mo have no ability to prime T cells for apoptosis unless treated with PMA prior to fixation and that unprimed PBT cells are resistant to apoptosis. Importantly, the findings suggest that upon culturing with fixed, PMA-pretreated Mo, further stimulation of PBT is required for apoptosis in that no apoptosis was observed for T cells cultured in medium alone or for T cells treated with anti-CD6 mAb plus goat anti-MsIgG. Although CD6 is present on virtually all T cells, crosslinking of CD6 with the 6D3 mAb does not result in T-cell activation (R.A.R., unpublished observation).
In addition to crosslinking by anti-CD4 mAb, it was found that if CD4 molecules on the cell surface of T cells were crosslinked by using a combination of gpl20, the envelope glycoprotein of HIV-1, plus anti-gpl20 mAb and GAMIgG, apoptosis of primed PBT cells increased by >2-fold when compared to unprimed PBT cells (Fig. 5B) . No increase in apoptotic cell death was observed by the binding of gpl20 alone without crosslinking.
DISCUSSION
Our data show that freshly isolated PBT cells can be readily induced to undergo apoptosis by stimulation via crosslinking of CD3 or CD4 molecules, ionomycin, or PMA through a major histocompatibility complex-nonrestricted Mo-dependent mechanism. Our findings suggest that Mo/macrophages play an important role in regulating T-cell death, which in itself may be essential for maintaining a normal T-cell repertoire.
When stimulated with PMA, Mo express and release a number of factors, among which are apoptosis-related mediators such as H202, 02- (17) , and type a tumor necrosis factor (TNF-a) (18 (20) . In support of the view that Mo play a crucial role in maintaining T-cell number in HIV-infected individuals was the observation that macrophage-tropic HIV strains but not T-cell-tropic HIV strains cause extensive CD4+ cell depletion in the hu-PBL-SCID model despite equivalent virus burden (21) . Banda et al. (22) have suggested that crosslinking of CD4 molecules with a combination of gp120 and anti-gp120 antibody can prime T cells for apoptosis since crosslinking of bound gpl20 on human CD4+ cells followed by engagement of T-cell receptor results in apoptosis in vitro (22) . This, however, cannot explain the death of CD8+ T cells from HIV+ individuals upon in vitro culture. Our demonstration that both CD4+ and CD8+ T cells can be primed for apoptosis by PMA-treated Mo and that the primed T cells can now undergo apoptosis upon polyclonal stimulation of T cells suggests a model whereby infection of macrophages with a macrophage-tropic HIV results in activation of these cells, either by direct infection or secondarily to cytokines released as a result of infection (23) . The activated macrophages would then be envisioned to facilitate induction of apoptosis on susceptible PBT cells in a manner similar to that described for PMA-treated Mo. This mechanism, applicable to other virus infections as well, might be used in lymphoid tissues where a high ratio of infected macrophages to T cells can be found (24) . These T cells would be particularly susceptible to apoptosis upon further stimulation, as might occur after antigen recognition, superantigen binding, CD4 molecule crosslinking by membrane-associated gp160 on the infected macrophages, and/or CD4 crosslinked by gp120 in the presence of anti-gp120 antibody. Such a process could result in the continuous and slow depletion of CD4+ cells and even of those activated CD8+ cells that are primed to kill virusinfected targets.
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